baber/WOPTO huggingface dataset:
Patent NZ-515724-A (NZ)
Title: A shelf assembly with stops slidable along backstop rail and pivotable about rail
Inventor: WAISBROD NEVILLE
IPC: A47B65/00
Filed: 1998-06-22
Abstract: Shelf assembly has shelf (2) having a front and a rear and a length direction. A rail (25) is disposed to with its longitudinal axis extending in the length direction of the shelf, adjacent to the rear of the shelf and above the level of the shelf to act as a backstop for items on the shelf. A retainer (27, 28, 29) has a single engagement portion (29) and a retaining arm (28). The engagement portion encircles the rail with its main axis aligned with the longitudinal axis of the rail, such that the engagement portion will engage with the rail. The retaining arm extends transversely across the shelf to act as a holder or stop for items on the shelf. The retainer is pivotable about the longitudinal axis of the rail.
Patent NZ-516202-A (NZ)
Title: Device for conveying flat objects with a routing system
Inventor: DARROU FABRICE
IPC: B65H29/58
Filed: 2000-07-05
Abstract: A device for conveying flat objects edge-on in series at high speed between an entry (A) and an exit (B) of a conveying path comprises a routing system for diverting some of these flat objects towards another exit (B') between the entry and the exit of the conveying path. This system comprises two mobile flaps (3, 4) kept mutually parallel and arranged between the entry and the exit of the conveying path, and two motorized endless belts (1, 2) moving between these two flaps and between which the flat objects conveyed are gripped, these two flaps being mounted so that they can pivot so as to route the flat objects either towards the exit (B) of the conveying path or towards the other exit (B'). A stationary post (6) is located at the point where the flat objects are routed downstream of the mobile flaps between the entry and the exit of the conveying path. The exit (B) of the conveying path is distant from the stationary post (6), and one (1) of the motorized endless belts extends beyond the stationary post as far as the exit of the conveying path, making it possible to ensure the continuity of the conveying of the envelopes exiting the routing system.
Patent NZ-518330-A (NZ)
Title: Indication means to indicate if the trailer brakes are functioning, being activated by the hydraulic fluid pressure of the trailer brake
Inventor: WALKLEY IAN FRANCIS
IPC: B60Q1/44
Filed: 2002-04-15
Abstract: A set of indication means are operated using sensors or switches that are activated by the hydraulic fluid pressure in a trailer's brake system. A junction block J is fixed to the hydraulic brake line H of a trailer. When the trailer brakes are applied, the switch P connected to the junction box J is turned on. This in turn illuminates the lamp L, indicating that the trailer brakes are being applied. An electric toggle switch T is utilised so that the beeper A can be turned on when the brake-preventing reversing lever is engaged. For power, the indication means is connected to a towing vehicle using a seven-pin trailer plug S. Using this, the wire W is only live when the towing vehicle's ignition is turned on. Addition to 518330
Patent NZ-518424-A (NZ)
Title: Water and oil containing emulsion
Inventor: BAUER-PLANK CHRISTINA
IPC: A23D7/00
Filed: 2000-11-02
Abstract: A food product with a Bostwick value of at least 7 at 15 °C, comprising an aqueous phase and from 40 to 90 wt% of a fat phase on total product, the fat phase comprising: (A) 0.1 to 1.5 wt% of one or more anti-splattering agents comprising no native soy lecithin or native soy lecithin in an amount of 0 to 0.05 wt% on total product, (B) optionally one or more emulsifiers in a total amount of from 0 to 0.5 wt%, (C) optionally one or more browning agents in a total amount of from 0 to 0.07 wt%, (D) one of more salts in an amount of 0.5 to 3 wt%.
Patent NZ-525572-A (NZ)
Title: Novel farnesyl protein transferase inhibitors
Inventor: NJOROGE F GEORGE
IPC: A61P35/00
Filed: 2001-11-27
Abstract: Compound useful for the inhibition of Farnesyl Protein Transferase. Also disclosed are pharmaceutical compositions comprising such compounds, as well as methods of using them to treat disorders associated with FPT. The compound is selected from the following group.
Patent NZ-526554-A (NZ)
Title: Substituted derivatives of aminofuran-2-YL-acetic acid and aminothien-2-YL-acetic acid and the use thereof for treating migraines and pain
Inventor: MAUL CORINNA
IPC: A61K31/381
Filed: 2001-11-28
Abstract: A compound of formula I or a pharmaceutically acceptable salt thereof; a process for the preparation of the compound; a medicament or pharmaceutical composition comprising the compound; and the use of the compound in the preparation of a medicament for the treatment of pain or migraine.
Patent NZ-529765-A (NZ)
Title: Native WI-FI architecture for 802.11 networks
IPC: H04L12/56
Filed: 2003-11-25
Abstract: A software based wireless infrastructure system comprises: a station driver for communicating with a first network stack and a first network interface card in communication with a wireless LAN; a station server in communication with the station driver and an 802.1X supplicant; an access point driver for communicating with the second network interface card and one of a network bridge and a second network stack in communication with a wired network, the second network interface card in communication with the wireless LAN and an access point server in communication with the access point driver and an 802.1X authenticator.
Patent NZ-532004-A (NZ)
Title: D-Mannose contraceptives
Inventor: BENEDICT DALE L
IPC: A61K31/70
Filed: 2002-08-29
Abstract: Disclosed is the use of D-mannose as a method of preventing conception by administration to a female human or animal in an amount between 1 gram and 10 grams per day in the form of a capsule or as a loose powder mixed with food or drink.
Patent NZ-535497-A (NZ)
Title: Organic mineral supplementation drench
Inventor: PICKERING ROBERT JAMES
Filed: 2004-09-23
Abstract: Disclosed is a method for controlling intestinal worms and or parasites in grazing stock, including breaking the worm cycle, enhancing the development of natural immunity to said parasites in the stock and providing means for selecting stock for breeding for internal parasite immunity comprising preparation of an oral drench product in the form of a smooth suspension containing zinc oxide, magnesium oxide and vegetable oil followed by appropriate application of the treatment to stock.
Patent NZ-537149-A (NZ)
Title: A cable terminal lug
Inventor: OGDEN BRUCE JAMES
Filed: 2004-12-13
Abstract: A cable terminal lug (100) has a barrel (101) defining a first tunnel (103) for receipt of a mains cable core strand (2). A palm (102) extends from the barrel and defines a generally flat first face (104). A mounting aperture (109) extends through the palm generally perpendicular to, and extending through, the first face. A first threaded aperture (110) extends through a wall of the barrel into the first tunnel. A first fastener (111) is threadingly received in the first threaded aperture. The first fastener has a leading end (111a) extendable into the first tunnel (103). A second tunnel (112) is provided for receipt of a first cable (12/14). A second threaded aperture (113) intersects the second tunnel. A second fastener (114) is threadingly received in the second threaded aperture. The second fastener has a leading end (114a) extendable into the second tunnel.
Patent NZ-539915-A (NZ)
Title: Controlled-release of an active substance into a high fat environment
Inventor: CHIDLAW MARK BRIAN
IPC: A61K9/20
Filed: 2003-11-28
Abstract: Disclosed is a use of a composition comprising an active-substance-containing core and an asymmetric polymeric coating thereon, in the manufacture of a medicament for controlled-release delivery upon administration of said composition to a use environment comprising at least about 0.5 wt% of dietary fat, wherein the polymer used to form said asymmetric polymeric coating comprises cellulose acetate, cellulose acetate butyrate, cellulose acetate propionate, cellulose acetate phthalate, hydroxypropyl methyl cellulose acetate succinate, polymethacrylate, or mixtures or-blends thereof.
Patent NZ-548941-A (NZ)
Title: Stacking implants for spinal fusion
Inventor: KNAACK DAVID
IPC: A61F2/00
Filed: 2005-01-31
Abstract: Disclosed is a system for inducing fusion of vertebrae, comprising: a plurality of stacking inserts for placement in an intervertebral space, each insert comprising a composite consisting essentially of bone fragments embedded in a biocompatible polymer, the composite having osteogenic properties, wherein a subset of said plurality of stacking inserts may be selected to fit the dimensions of the intervertebral space. Also disclosed is the use of a composite consisting essentially of bone fragments embedded in a biocompatible polymer, the composite having osteogenic properties, in the manufacture of a plurality of stackable inserts for fusing adjacent vertebrae, wherein the plurality of inserts, when inserted into an intervertebral space, together match the size and shape of the intervertebral space.
Patent NZ-551673-A (NZ)
Title: 3-Aminocyclopentanecarboxamides as modulators of chemokine receptors
Inventor: XUE CHU-BIAO
IPC: A61K31/4433
Filed: 2005-06-27
Abstract: Disclosed is a 3-aminocyclopentanecarboxamide compound of Formula (I) wherein the substituents are defined within the specification. Disclosed is the use of a compound of formula for the manufacture of a medicament for modulating activity of a chemokine receptor such as CCR2 or CCR5 and hence the diseases associated with chemokine receptors such as an immune disorder, an inflammatory disease, cancer or a viral infection.
Patent NZ-554430-A (NZ)
Title: N-phenyl-2-pyrimidine-amine derivatives
Inventor: LOISELEUR OLIVIER
IPC: A61K31/506
Filed: 2003-02-06
Abstract: Disclosed is the preparation of a compound of formula I, wherein a compound of formula II is reacted with an amine of formula III, wherein the substituents of the three compounds are described within the specification: in the presence of 1) a Lewis acid selected from Al(lower alkyl)3, AlCl3, EtAlCl2, MeAlCl2, Me2AlCl, Et2AlCl or the corresponding sesquichlorides, 2) an organic solvent, and optionally 3) a base, 4) and the resulting product is hydrolysed
Patent NZ-564139-A (NZ)
Title: Holder assembly, as three piece garage hook, with drywall fasteners and apertured base plate typically having U-shaped outstand
Inventor: HORVATH JOHN F
IPC: F16B25/00
Filed: 2006-05-30
Abstract: In one aspect, a holder mountable to a friable substrate may include a self-drilling drywall fastener, a wall engaging base plate having an opening for receiving a fastener, and at least one leg extending from the base plate for holding an object. In another aspect, a holder may include a self-drilling drywall fastener having a drilling portion longer than a drywall thickness followed by a high-threaded portion, a wall engaging base plate, and at least one leg for holding an object. In still another aspect, a holder may include a self-drilling drywall fastener having a screw-like drilling portion longer than a drywall thickness followed by a high-threaded portion, a drywall engaging base plate having a recess for receiving a rotary driver and a pair of openings each capable of receiving a threaded drywall fastener and engaging threads thereof.
Patent NZ-565078-A (NZ)
Title: Deuterated proton pump inhibitors such as omeprazole
Inventor: KOHL BERNHARD
IPC: A61K31/4439
Filed: 2006-07-26
Abstract: Disclosed is a compound of formula (1), or a pharmaceutically acceptable salt, solvate, or solvate of a salt thereof, wherein R1 is H or 1-4C-alkoxy, R2 is 1-4C-alkyl or 1-4C-alkoxy, R3 is 1-4C-alkyl, 1-4C-alkoxy, or 2-8C-alkoxyalkoxy, R4 is hydrogen or 1-4C-alkyl, and Z is CH or N, and wherein at least one hydrogen atom of R1, R2, R3, R4, or combinations thereof is replaced by a deuterium atom. Also disclosed is a compound of formula (2), or a pharmaceutically acceptable salt, solvate, or solvate of a salt thereof, wherein the substituents are as described for formula (1) above, and wherein at least one hydrogen atom of R1, R2, R3, R4, or combinations thereof is replaced by a deuterium atom. Also disclosed are intermediates for preparing the compounds of formula (1) or (2).
Patent NZ-585929-A (NZ)
Title: Method and device for producing a printed and embossed web
Inventor: SCHINKOREIT WOLFRAM
IPC: B31F1/07
Filed: 2007-12-20
Abstract: A method and device are disclosed for producing a printed and embossed multi-ply web (3) of tissue paper or nonwoven having a good visual appearance. A first web-shaped material (1) is embossed in a nip (6) between a first embossing roll (4) and a counter roll (5), thereby creating a set of embossments. A first ink with a first colour is applied to a first subset of said set of embossments of said first web-shaped material while the material still resides on said first embossing roll. Thereafter an adhesive is applied to a second subset of said set of embossments of said first web-shaped material (1) while the material still resides on said first embossing roll (4). After that, said first web-shaped material is combined with a second web-shaped material (2) to form a multi-ply web (3). There is also provided a printed and embossed multi-ply web (3).
Patent NZ-586054-A (NZ)
Title: A nail with rows of spiral deformation along the shank
Inventor: VERSINO ANTHONY M
IPC: F16B15/06
Filed: 2008-12-09
Abstract: 586054 A nail comprising a head, a penetrating tip, a shank extending from the head to the penetrating tip and having a circumference and a longitudinal axis, and a plurality of rows of deformations in the shank extending outwardly of the shank. The rows are formed in a spiral pattern along the length of the shank from about the head to about the penetrating tip, the rows of deformations being formed parallel to one another and formed at an angle of at least 50 degrees relative to a perpendicular to a longitudinal axis of the nail. The deformations are formed as teeth extending outwardly from the shank and are formed with a leading portion tapering toward the penetrating tip and a trailing portion having an interference surface oriented toward the head, opposite the leading portion, and wherein the teeth overlap one another at adjacent leading ends and trailing ends.
Patent NZ-590809-A (NZ)
Title: Pesticidal compositions comprising sulphamide compounds
Inventor: NUGENT BENJAMIN
IPC: A01P1/00
Filed: 2009-08-25
Abstract: Disclosed is a composition comprising a sulfamide compound of general formula (I), wherein R1 is pyrimidinyl, pyridazinyl or pyrazinyl. Examples of the compounds of formula (I) include [1-(2-chloropyrimidin-5-yl)ethyl](methyl)oxido-delta-sulfanylidenecyanamide and [(3-chloropyridazin -6-yl ) methyl ] (methyl )oxido-delta-sulfanylidenecyanamide. The composition is useful as a pesticide. A process for preparing the compounds is also disclosed.
Patent NZ-592658-A (NZ)
Title: Aquaculture dropper rope with densifier material in polymer material of at least one yarn of rope so that it sinks in water
Inventor: MCDONALD TONY
IPC: A01K71/00
Filed: 2011-05-04
Abstract: 592568 An aquaculture dropper rope is disclosed with the rope including a rope portion of rope material and further including at least one strand of flexible polymer material which in turn includes at least one densifier material therein, sufficient so that the rope sinks when immersed in water.
Patent NZ-592741-A (NZ)
Title: Thiochromene derivatives as hif hydroxylase inhibitors
Inventor: HO WEN-BIN
IPC: A61P9/10
Filed: 2009-11-11
Abstract: 592741 Disclosed is a compound of formula I which inhibits hypoxia inducible factor (HIF) hydroxylase enzyme activity, wherein the substituents are as described within the specification. An example of a compound of formula I is [(4-hydroxy-7-methoxy-2-oxo-2H-thiochromene-3-carbonyl)-amino]-acetic acid. Further disclosed is a pharmaceutical composition comprising a compound of formula I and the use of a compound of formula I in the manufacture of a medicament for treating a condition mediated by HIF or erythropoietin, such as myocardial infarction, congestive heart failure, or anaemia. Also disclosed is a method of inhibiting the activity of HIF hydroxylase which is not present in the human body.
Patent NZ-593913-A (NZ)
Title: Metered delivery of wireless power
Inventor: TAYLOR JOSHUA B
IPC: G06Q30/06
Filed: 2009-12-29
Abstract: 593913 Disclosed is a wireless charging system (102) with billing capabilities. The wireless charging system (102) is comprised of a detector that automatically detects a presence of a device (206) when within range and identifies the device (206) to be powered. The system (102) also includes a billing processor (204) coupled with the detector and operative to automatically authorise delivery of power to the device (206) upon the detection and the identification. A power supply (202) coupled with the billing processor (204) is also provided. The power supply (202) is operative to automatically wirelessly provide power to the device (206) upon the authorisation of delivery by the billing processor (204). The billing processor (204) is further operative to account for the power provided to the device (206) by the power supply (202) to arrange for compensation for the provided power.
Patent NZ-595500-A (NZ)
Title: Cellulolytic enzymes, nucleic acids encoding them and methods for making and using them
Inventor: GRAY KEVIN A
IPC: A23L35/00
Filed: 2006-12-08
Abstract: Disclosed is an isolated, synthetic or recombinant nucleic acid comprising a nucleic acid sequence having at least 70% or more sequence identity to SEQ ID NO: 387, as defined in the complete specification. The disclosed nucleic acid encodes a polypeptide having a beta-glucosidase activity.
Patent NZ-599737-A (NZ)
Title: Il-17a antagonists
Inventor: ELLOSO MERLE
IPC: C07K16/24
Filed: 2010-10-29
Abstract: Disclosed is an isolated antibody or fragment thereof that binds specifically to human IL-17A, comprising the CDRs/heavy and light chains of the SEQ IDs as disclosed within the specification. Also disclosed is the use of the antibody for treating an inflammatory condition.
Patent NZ-600337-A (NZ)
Title: Improvements in and relating to paperboard
Inventor: ROGERS JASON PAUL
IPC: A47F5/11
Filed: 2012-09-21
Abstract: A laminated support member (2) is disclosed comprising a plurality of single or double face paperboard layers laminated together. At least one rebate runs along the length of the support member. The width and depth of the rebate are designed to hold a sheet of paperboard material (3) forming at least one display surface, firmly and in a substantially vertical orientation. The width of the support member (3) is sufficient to allow the support member (2) to act as a stabilizing base. A sign assembly (1) is also disclosed comprising such a laminated support member (3) and a sheet of paperboard material (2) displaying a graphic image and/or message.
Patent NZ-600801-A (NZ)
Title: Substituted imidazopyridinyl-aminopyridine compounds
Inventor: HILL JASON
IPC: A61K31/4188
Filed: 2010-12-29
Abstract: Disclosed herein are substituted imidazopyridinyl-aminopyridine compounds of formula (I)-(IV), wherein the substituents are as defined within the specification, processes for their preparation, compositions comprising said compounds and uses thereof. Examples of particularly preferred compounds include: N-(4-(5-(4-acetamidophenyl)-2-(2-aminopyridin-3-yl)-3H-imidazo[4,5-b]pyridin-3-yl)benzyl)benzamide N-(4-(2-(2-aminopyridin-3-yl)-6-(1Hpyrrol-3-yl)-3H-imidazo[4,5-b]pyridin-3-yl)benzyl)benzamide 4-acetamido-N-(4-(2-(2-aminopyridin-3-yl)-6-(pyridin-3-yl)-3H-imidazo[4,5-b]pyridin-3-yl)benzyl)benzamide N-(4-(2-(2-aminopyridin-3-yl)-6-(pyridin-3-yl)-3H-imidazo[4,5-b]pyridin-3-yl)benzyl)-3-fluorobenzamide N-(4-(2-(2-aminopyridin-3-yl)-6-(pyridin-3-yl)-3H-imidazo[4,5-b]pyridin-3-yl)benzyl)-2-methylquinoline-6-carboxamide.
Patent NZ-607114-A (NZ)
Title: Power oscillation damping by a converter-based power generation device
Inventor: ANDRESEN BJÖRN
IPC: H02P9/48
Filed: 2011-01-19
Abstract: 607114 There is provided a power generation park (100) comprising a power output (108) for providing electrical output power (150) to an electricity network (128). A power generation device (102a,... 102n) comprises a converter device (106) configured for receiving input power (142) from a power generator (104) and providing, in response hereto, the electrical output power (150) to the power output (112). The power generation park (100) further comprises a controller (122) being configured for receiving an oscillation indicating signal (126) indicative of a power oscillation in the electricity network (108), the controller (122) being further configured for providing a damping control signal (132) in response to the oscillation indicating signal (126); the converter device (106) being configured for modulating the electrical output power (150) in response to the damping control signal (132)so as to damp the power oscillation in the electricity network (128).
Patent NZ-607357-A (NZ)
Title: Scalable packets in a frequency hopping spread spectrum (fhss) system
Inventor: HEMMINGER RODNEY C
IPC: H04W92/18
Filed: 2013-02-20
Abstract: Disclosed is a wireless network (112) with a transmitting communication node communicating a communication packet with a preamble portion communicated on a dedicated acquisition channel of a frequency spectrum and a data portion communicated on at least one dedicated data channel of the frequency spectrum. The network (112) also includes a receiving communication node that receives the communication packet from the transmitting communication node. The frequency spectrum is divided into a set of dedicated acquisition channels and a set of dedicated data channels. A length of the preamble portion is determined based at least in part on a data packet length associated with the communication packet and a number of acquisition channels in the set of dedicated acquisition channels.
Patent NZ-612773-A (NZ)
Title: High temperature temporary diverter and lost circulation material
Inventor: BOUR DANIEL L
IPC: E21B33/13
Filed: 2011-12-14
Abstract: Disclosed is a method for introducing a particulate diverting agent into a fracture (500, 510) within an underground reservoir formation (520). The disclosure notes that fractured zones (500, 510) within a well (520) are areas where both drilling fluid is lost but are also potential productive zones and therefore should not be permanently hydraulically isolated. The method comprises the steps of introducing a particulate diverting agent into a first fracture (500) within an underground reservoir formation (520). The particulate diverting agent is sufficient to at least partially isolate the first fracture (500). The particulate diverting agent is a temporary material which substantially degrades over an extended time. The underground reservoir formation (520) is stimulated with a stimulation fluid sufficient to expand a second fracture (510). The particulate diverting agent is allowed to substantially degrade by reducing the flow of the stimulation fluid to allow native heat within the formation to heat the particulate diverting agent to a degradation temperature.